secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001104659-24-086761
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana Health Q2 revenue up 40% to $486.3M, EPS $0.40; acquires CHS from Centene
--------------------------------------------------------------------------------

- Q2 revenue $486.3M (+40% YoY), net income $19.2M (+46%), diluted EPS $0.40 (+43%), adjusted EBITDA $47.9M (+34%).
- Six-month revenue $890.6M (+30%), net income $34.0M (+29%), diluted EPS $0.71, adjusted EBITDA $90.2M (+38%).
- Entered Arizona via partnership with 45+ PCP group; Hawaii via Elation Health partnership covering ~20K Medicare patients.
- Definitive agreement to acquire Collaborative Health Systems from Centene (~2,500 PCPs, 100K+ beneficiaries) expected Q4 2024.
- Updated FY2024 revenue guidance $1.75B-$1.85B; reiterated adjusted EBITDA $165M-$185M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465924086761/0001104659-24-086761-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465924086761/tm2420865d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-086761

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer